for use in connective tissue research. The mice were immunized with a chondroitin sulfate proteoglycan preparation that had been treated with chondroitinase ABC, which cleaves off chondroitin sulfate glycosaminoglycan chains distal to the basal hexasaccharides, leaving a hexuronic acid at the non-reducing terminus. Thus the epitope to these MAbs are generated by the enzyme treatment (1). Couchman et al. have shown immunohistochemical staining of cartileage and skin tissues on chondroitinase treated sections (1) . In sections of mammalian central nervous tissues that had been treated with chondroitinase ABC, perineuronal staining of some neurons were seen for each of the three MAbs ( Fig. 3) (4) . MAb 9A2 stained neuropil in addition (Fig. 3B) . In untreated sections, MAbs 1B5 and 9A2 were negative, and MAb 3B3 stained much fewer neurons. Staining of embryonic cartilaginous tissues by the three MAbs were similarly dependent on chondroitinase ABC treatment, in basic agreement with Couchman et al. (1) . Because of the established specificity of these MAbs and expected dependence of staining on chondroitinase treatment, these observations present strong evidence for association of certain chondroitin sulfate proteoglycan with some populations of central neurons.
Dual color immunoflourescence staining of the same sections indicated that neurons positive to MAbs 9A2 or 3B3 are generally also positive to MAb 1B5 that gives the most intense staining. Comparison of MAbs 473 or 376 with MAb 1B5 indicated that 473-positive and 376-positive subsets are contained within the 1B5positive neuronal population. Occurrence of chondroitinase-inactivated epitopes of MAbs 473, 376, and 528 on the very neurons expressing chondroitinase-uncovered epitopes of MAb 1B5 suggests that the former epitopes may, in some way, be closely related to the latter.
Prospects.
Multiple lines of evidence reviewed above point to the occurrence of chondroitin sulfate-like molecules on at least some central neurons. It is important to establish the molecular nature of the antigens involved. This will be achieved by fractionation through electrophoretic and other biochemical methods combined with immunochemical detection.
Before inquiring into the roles played by such molecules, it will be necessary to characterize the neuroanatomical features of positive neurons with respect to cell types and connectivity. Since the 6 MAbs mentioned above together stain only a small portion of neurons, it is intriguing to know whether this specialsubsetalone expresses proteoglycan-like molecules, or alternatively, the above observation bears only on the tip of an iceberg that comprises a complex molecular family differentially expressed in virtually all central neurons. It is interesting therefore to note that we have recently found a perineuronally staining MAb that defines a new subset very much different from the ones discussed above. This immunoreactivity is resistent to chondroitinase treatment. We continue to search for different MAbs of the kind.
Heparin is known to bind various kinds of growth factors, especially those deriving from the brain and retina (10) . It has recently been shown that heparan sulfate of the bone marrow stroma cells adsorbs hematopoietic growth factors to be presented in the biologically active form to hematopoietic stem cells (14) . It is tempting to speculate whether similar mechanisms may operate in the central nervous system, internalized to be transported back to lysosomes or perhaps even to nuclei (7 , 8) .
Thus the synaptic proteoglycans are in a position to translate the amount of synaptic activity into material deposit, which might in turn stabilize the synapse , and even relay this information back to the nuclei. In order to determine the physiological roles played by the antigens discussed in this report, it will be necessary to study their appearance during development and to delineate conditions that lead to alteration in expression of the antigens . The latter approach will involve surgical deafferentation, pharmacological perturbation, and genetic manipulation. It indeed seems a long way to go before we understand the significance of such antigen molecules in the brain, but it certainly is full of attractions of trails never trodden before.
